Alnylam Pharmaceuticals, Inc. (LON:0HD2)
433.22
+3.11 (0.72%)
At close: Aug 13, 2025
Alnylam Pharmaceuticals Employees
Alnylam Pharmaceuticals had 2,230 employees as of December 31, 2024. The number of employees increased by 130 or 6.19% compared to the previous year.
Employees
2,230
Change (1Y)
130
Growth (1Y)
6.19%
Revenue / Employee
805.82K GBP
Profits / Employee
-104.44K GBP
Market Cap
41.78B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
Oxford Nanopore Technologies | 1,382 |
HUTCHMED (China) | 1,811 |
Alnylam Pharmaceuticals News
- 1 day ago - Here's How Much $100 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth Today - Benzinga
- 3 days ago - Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025 - Business Wire
- 9 days ago - Alnylam to Webcast Presentation at Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 10 days ago - This Alnylam Pharmaceuticals Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday - Benzinga
- 11 days ago - Reddit, Wingstop, And Generac Are Among Top 10 Large Cap Gainers Last Week (July 28-August 1): Are The Others In Your Portfolio? - Benzinga
- 12 days ago - Alnylam's Amvuttra Makes Powerful Entrance, Eyes First-Line Dominance - Benzinga
- 12 days ago - Alnylam's Amvuttra Makes Powerful Entrance, Eyes First-Line Dominance - Benzinga
- 13 days ago - Alnylam Pharmaceuticals, Inc. (ALNY) Q2 2025 Earnings Call Transcript - Seeking Alpha